BioAdaptives, Inc.
BDPT
$0.02
$0.007.83%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -60.80% | -90.99% | -98.11% | -55.44% | -21.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -60.80% | -90.99% | -98.11% | -55.44% | -21.34% |
| Cost of Revenue | -96.83% | 36.70% | 230.36% | 408.47% | 483.33% |
| Gross Profit | 106.70% | -494.95% | -747.20% | -809.17% | -910.87% |
| SG&A Expenses | 366.93% | 286.34% | 189.29% | 138.56% | 48.14% |
| Depreciation & Amortization | 128.09% | -96.52% | -100.00% | -93.26% | -122.42% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 246.86% | 215.11% | 163.97% | 131.64% | 49.34% |
| Operating Income | -266.71% | -254.20% | -201.62% | -155.13% | -58.69% |
| Income Before Tax | -39.05% | 0.87% | -7.86% | -26.19% | -68.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.05% | 0.87% | -7.86% | -26.19% | -68.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.05% | 0.87% | -7.86% | -26.19% | -68.38% |
| EBIT | -266.71% | -254.20% | -201.62% | -155.13% | -58.69% |
| EBITDA | -276.93% | -324.89% | -268.42% | -218.26% | -93.48% |
| EPS Basic | 9.31% | 34.39% | -13.51% | 38.17% | 46.96% |
| Normalized Basic EPS | 4.71% | 14.16% | -36.26% | 34.28% | 36.03% |
| EPS Diluted | 9.31% | 34.39% | -13.51% | 38.17% | 46.96% |
| Normalized Diluted EPS | 4.71% | 14.16% | -36.26% | 34.28% | 36.03% |
| Average Basic Shares Outstanding | 16.92% | 23.24% | 1.40% | 20.91% | 204.78% |
| Average Diluted Shares Outstanding | 16.92% | 23.24% | 1.40% | 20.91% | 204.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |